LINAGLIPTIN\METFORMIN: 667 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
667
Total FAERS Reports
28 (4.2%)
Deaths Reported
222
Hospitalizations
667
As Primary/Secondary Suspect
30
Life-Threatening
10
Disabilities
Active Ingredient: LINAGLIPTIN\METFORMIN HYDROCHLORIDE ·
First Report: 2009 · Latest Report: 20250909
What Are the Most Common LINAGLIPTIN\METFORMIN Side Effects?
#1 Most Reported
Blood glucose increased
63 reports (9.4%)
#2 Most Reported
Diarrhoea
50 reports (7.5%)
#3 Most Reported
Acute kidney injury
37 reports (5.5%)
All LINAGLIPTIN\METFORMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Blood glucose increased | 63 | 9.5% | 1 | 11 |
| Diarrhoea | 50 | 7.5% | 2 | 18 |
| Acute kidney injury | 37 | 5.6% | 2 | 33 |
| Dizziness | 32 | 4.8% | 0 | 15 |
| Nausea | 32 | 4.8% | 1 | 7 |
| Vomiting | 32 | 4.8% | 3 | 13 |
| Pancreatitis | 29 | 4.4% | 0 | 13 |
| Dehydration | 25 | 3.8% | 0 | 23 |
| Lactic acidosis | 23 | 3.5% | 5 | 13 |
| Atrial fibrillation | 19 | 2.9% | 0 | 18 |
| Metabolic acidosis | 18 | 2.7% | 0 | 17 |
| Weight decreased | 18 | 2.7% | 0 | 10 |
| Confusional state | 17 | 2.6% | 0 | 10 |
| Arrhythmia | 16 | 2.4% | 0 | 15 |
| Asthenia | 16 | 2.4% | 0 | 5 |
| Diabetic ketoacidosis | 16 | 2.4% | 1 | 13 |
| Fatigue | 16 | 2.4% | 0 | 3 |
| Hypoglycaemia | 16 | 2.4% | 0 | 8 |
| Hypotension | 16 | 2.4% | 0 | 16 |
| Presyncope | 16 | 2.4% | 0 | 15 |
Who Reports LINAGLIPTIN\METFORMIN Side Effects? Age & Gender Data
Gender: 55.9% female, 44.1% male. Average age: 64.7 years. Most reports from: US. View detailed demographics →
Is LINAGLIPTIN\METFORMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 1 |
| 2012 | 2 | 0 | 0 |
| 2013 | 4 | 1 | 0 |
| 2014 | 49 | 3 | 19 |
| 2015 | 58 | 1 | 16 |
| 2016 | 59 | 0 | 19 |
| 2017 | 42 | 0 | 13 |
| 2018 | 42 | 0 | 24 |
| 2019 | 26 | 3 | 15 |
| 2020 | 38 | 2 | 9 |
| 2021 | 30 | 0 | 16 |
| 2022 | 17 | 3 | 6 |
| 2023 | 9 | 2 | 3 |
| 2024 | 19 | 0 | 10 |
| 2025 | 16 | 2 | 7 |
What Is LINAGLIPTIN\METFORMIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 250 |
| Type 2 diabetes mellitus | 235 |
| Diabetes mellitus | 136 |
| Blood glucose increased | 6 |
LINAGLIPTIN\METFORMIN vs Alternatives: Which Is Safer?
LINAGLIPTIN\METFORMIN vs LINCOMYCIN
LINAGLIPTIN\METFORMIN vs LINEZOLID
LINAGLIPTIN\METFORMIN vs LINZESS
LINAGLIPTIN\METFORMIN vs LIORESAL
LINAGLIPTIN\METFORMIN vs LIORESAL INTRATHECAL /ML
LINAGLIPTIN\METFORMIN vs LIOTHYRONINE
LINAGLIPTIN\METFORMIN vs LIPEGFILGRASTIM
LINAGLIPTIN\METFORMIN vs LIPITOR
LINAGLIPTIN\METFORMIN vs LIRAGLUTIDE
LINAGLIPTIN\METFORMIN vs LISDEXAMFETAMINE
Official FDA Label for LINAGLIPTIN\METFORMIN
Official prescribing information from the FDA-approved drug label.